Point72 Middle East FZE’s Revance Therapeutics, Inc. RVNC Stock Holding History

Point72 Middle East FZE’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$653K	Buy
2023 Q3	$23.9K	Sell
2023 Q2	$854K	Buy
2023 Q1	–	Sell
2022 Q4	$149K	Buy